|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Virginia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing VirginiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Diffusion Pharmaceuticals LLC
| | | Phone: | (434) 220-0718 | Fax: | (434) 220-0722 | Year Established: | 2001 | Main Contact: | David G. Kalergis, JD/MBA, CEO & Co-Founder | | Other Contacts: | Thomas E. Byrne, JD, General Counsel David R. Jones, M.D., CMO John L. Gainer, Ph.D., CSO & Co-Founder Kelly Hoy, Senior Project Manager Ben Shealy, CFA/MBA, CFO David G. Kalergis, JD/MBA, CEO & Co-Founder
| | Company Description | Diffusion Pharmaceuticals is a clinical-stage biotech company developing new, small-molecule drugs that help regulate the movement of oxygen into tissue by a novel mechanism of action. The Company’s lead drug, trans sodium crocetinate (TSC), uses this novel mechanism to re-oxygenate the microenvironment of solid cancerous tumors, thereby significantly enhancing tumor cells’ response to conventional treatment without additional side effects. | |
|
|
|
|
|